Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond.
about
Biocompatibility and biodegradation studies of subconjunctival implants in rabbit eyesPotential penetration of topical ranibizumab (Lucentis) in the rabbit eye.Ocular drug delivery.Noninvasive routes of proteins and peptides drug delivery.Efficacy of Antibody Delivery to the Retina and Optic Nerve by Topical AdministrationIFN{gamma} regulates retinal pigment epithelial fluid transport.Ophthalmic drug delivery in glaucoma-a review.Nerve growth factor modulation of retinal ganglion cell physiology.Improved brain uptake of peptide-based CNS drugs via alternative routes of administrations of its nanocarrier delivery systems: a promising strategy for CNS targeting delivery of peptides.In vitro and ex vivo corneal penetration and absorption models.Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.The Effect of Diluted Penetration Enhancer in Nebulized Mist versus Liquid Drop Preparation Forms on Retrobulbar Blood Flow in Healthy Human Subjects.Ocular and systemic pharmacokinetics of lidocaine hydrochloride ophthalmic gel in rabbits after topical ocular administration.Systemic and periocular deliveries of plasminogen kringle 5 reduce vascular leakage in rat models of oxygen-induced retinopathy and diabetes.Ophthalmic Formulation Containing Nilvadipine Nanoparticles Prevents Retinal Dysfunction in Rats Injected with Streptozotocin.Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera.Intracameral Use of Nepafenac: Safety and Efficacy Study.Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.Long-Term Subconjunctival Delivery of Brimonidine Tartrate for Glaucoma Treatment Using a Microspheres/Carrier System.
P2860
Q28479248-7AA10264-3BE6-4275-8026-7C9AE9E17130Q30424219-39459F09-90E8-47B3-BD6E-0F1D6BA88D36Q30475605-7BD40549-F140-4028-9BA2-91BC2C639558Q36029817-71F2EE16-B60C-434A-BC13-4E32A0E88D94Q36881990-1E658680-6EEB-4F5C-9BBE-E51BB8AE4B7FQ37474481-36D4EC6D-361F-46F1-9542-79565CF9574DQ38168357-43EFBD76-076D-46A6-A5AE-2ADA31DB8E8EQ38185629-28863655-BBF6-422C-828F-34B3DBA947A8Q38246688-96472385-25B5-448B-A143-668AD3EBB605Q38695101-BD251D6C-AA07-4AAA-942B-DC33EFDA3A90Q41612480-4A339DF9-CA4A-4DFA-A65E-B34494360EABQ41988607-BE8F233F-0130-4862-85C0-32C7557A4509Q45929402-C0E04DC0-2212-4600-9C4C-13CD88E21487Q46658213-B82DF886-0C5A-419B-9D24-E73A897E9FEDQ47324796-1DA430DC-C63E-449F-9CFA-CB58C4D6B46EQ48238962-1326D091-354D-47CA-8728-E6F7FBC2F9E8Q49330579-07A0C722-32A7-410D-9E50-2D1688CA1B5AQ50097437-3A65BF2C-4690-408C-A47E-B5DACB3BC340Q51167186-7924D258-6CDC-48C1-9BD4-4B37ECA0FAE1
P2860
Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacokinetics of topical oc ...... posterior segment and beyond.
@ast
Pharmacokinetics of topical oc ...... posterior segment and beyond.
@en
type
label
Pharmacokinetics of topical oc ...... posterior segment and beyond.
@ast
Pharmacokinetics of topical oc ...... posterior segment and beyond.
@en
prefLabel
Pharmacokinetics of topical oc ...... posterior segment and beyond.
@ast
Pharmacokinetics of topical oc ...... posterior segment and beyond.
@en
P356
P1476
Pharmacokinetics of topical oc ...... posterior segment and beyond.
@en
P2093
Steven B Koevary
P304
P356
10.2174/1389200033489488
P407
P577
2003-06-01T00:00:00Z